Premenstrual Syndrome (PMS). Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Contrtol group: patients with PMS (23 girls) which use placebo (one capsule filled with senjed powder for each day after lunch during 8 weeks). Intervention 2: Intervention group: sin
Placebo
Treatment - Drugs
Contrtol group: patients with PMS (23 girls) which use placebo (one capsule filled with senjed powder for each day after lunch during 8 weeks)
Intervention group: single patients with PMS during 8 weeks will use of one capsule of soybean supplementation each day
Intervention group: single patients (23 girls) with PMS and regular aquatic exercise during 8 weeks with 50-60% heart rate for 30 minutes
Intervention group: patients with PMS (23 girls) and regular aquatic exercise with 50-60% heart rate for 30 minutes will use of one capsule of soybean supplementation each day during 8 weeks
Sponsors
Vice chancellor for research, Shahroud University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 24 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: female gender between the ages 18-24 year old; Single; normal cycle (duration of cycle 21-35, bleeding 3-10 days); normal BMI with PMS. Exclusion criteria: any history of disease such as hepatic; renal or respiratory cardiac; diabetes; or respiratory diseases, presence of secondary dysmenorrheal; sea food allergy; use of alcohol, smoking; presence of chronic diseases such as like migraine; use of any drug affecting PMS such as OCP or B6; stressful condition like death of family members.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body fat percentage. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Waist-to-hip ratio (WHR). Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Premenstrual syndrome (existing symptoms in PSST questionnaire). Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Body water. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Fat-free mass index. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Body Mass Index. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Skeletal muscle mass. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Body Fat Mass. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Weight. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Basal Metabolic Rate (BMR). Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer.;Body impedance analysis. Timepoint: 8 weeks after intervention. Method of measurement: Body analyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hamid Kalalian Moghadam
Shahroud University of Medical Sciences
Outcome results
None listed